454 unknown. 454 Phase 2, 90 Phase 1, 83 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 454 | Unknown 454 |
| Phase 1 | 90 | Unknown 90 |
| Phase 3 | 83 | Unknown 83 |
Follow Mental Disorders: new trials by email Literature Review of Mental Disorders trials Research Report on Mental Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study Prednisone, Placebo - Restless Legs Syndrome | Phase 1 / Phase 2 | Unknown | Scripps Health | 50 | 2024-10-01 | 2024-10-08 |
| Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population Motivational interviewing - Alcohol Abuse | Phase 1 / Phase 2 | Unknown | Department of Public Health Medicine, MARA University of Technology | 36 | 2024-10-01 | 2024-09-04 |
| Black Seed Oil in ADHD Atomoxetine, Black Seed Oil Cap/Tab - ADHD | Phase 2 | Unknown | Ain Shams University | 60 | 2024-10-01 | 2024-08-09 |
| Intranasal Oxytocin in Youth With Autism Oxytocin nasal spray, Placebo - Autism Spectrum Disorder | Phase 2 | Unknown | Oslo University Hospital | 128 | 2024-09-18 | 2024-06-24 |
| Cannabidiol's Role in Dementia Management Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed | Phase 2 / Phase 3 | Unknown | Hospital Pengajar Universiti Putra Malaysia | 486 | 2024-09-01 | 2024-07-23 |
| Psilocybin-assisted Therapy for Alcohol Use Disorder Psilocybin, Niacin - Alcohol Use Disorder, Alcohol Dependence | Phase 2 | Unknown | University of Sydney | 90 | 2024-09-01 | 2024-06-10 |
| The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD Oral CBD oil enriched with terpenes, Oral Placebo - Attention Deficit Hyperactivity Disorder (ADHD) | Phase 2 | Unknown | Bazelet Nehushtan LtD. | 120 | 2024-08-22 | 2024-08-23 |
| Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders MTP-101P, Vancomycin, Miralax - Autism Spectrum Disorder, Gastro-Intestinal Disorder | Phase 2 | Unknown | Gut-Brain-Axis Therapeutics Inc. | 60 | 2024-08-20 | 2024-09-25 |
| Erectile Dysfunction Treatment Using Stem Cells UC-MSCs and PRP - Erectile Dysfunction | Phase 1 / Phase 2 | Unknown | COR clinic of Regenerative Medicine | 30 | 2024-08-10 | 2024-08-13 |
| Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries Ketamine, Dexmedetomidine - Emergence Delirium | Phase 1 / Phase 2 | Unknown | Cairo University | 46 | 2024-08-10 | 2024-08-20 |
| Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency Vit D, Placebo - Psychiatric Disorder | Phase 1 / Phase 2 | Unknown | German University in Cairo | 70 | 2024-06-30 | 2024-06-13 |
| Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease 10g Astragalus, Routine treatment, 20g Astragalus - Alzheimer's Disease | Phase 2 | Unknown | Fujian Medical University Union Hospital | 66 | 2024-05-01 | 2024-07-03 |
| Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder HS-10506, Placebo - Insomnia Disorder | Phase 1 / Phase 2 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 312 | 2024-05-01 | 2024-04-23 |
| Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke Pentoxifylline - Cognitive Impairment | Phase 1 / Phase 2 | Unknown | The First Hospital of Hebei Medical University | 200 | 2024-04-10 | 2024-04-03 |
| Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD Modified Atkin's Diet with standard of care, Standard of Care - Modified Atkins Diet, Autism Spectrum Disorder | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 80 | 2024-03-20 | 2024-03-18 |
| The Effect of Naldemedine on Opioid-induced Bowel Dysfunction Naldemedine, Placebo, Tramadol - Opioid-Induced Bowel Dysfunction, Constipation | Phase 2 | Unknown | Asbjørn Mohr Drewes | 20 | 2024-03-12 | 2024-03-28 |
| Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty Remimazolam 20 MG Injection [Byfavo], NaCl 0.9% - Remimazolam, Emergence Delirium | Phase 2 | Unknown | University Hospital of Split | 80 | 2024-03-06 | 2024-05-03 |
| Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome Chylobinoid Topical Cream - Restless Legs Syndrome | Phase 1 / Phase 2 | Unknown | Synthonics Inc | 10 | 2024-03-01 | 2024-08-28 |
| Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension Routine treatment, add-on low dose Astragalus, add-on high dose Astragalus - Orthostatic Hypotension, Alzheimer Disease | Phase 2 | Unknown | Fujian Medical University Union Hospital | 66 | 2024-02-20 | 2024-01-05 |
| Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder Psilocybin (high dose), Active placebo (low dose of psilocybin) - Severe Alcohol Use Disorder | Phase 2 | Unknown | Brugmann University Hospital | 62 | 2024-02-15 | 2024-08-07 |
Showing 20 of 454. Sign in to see all of them.
Alzheimer Disease (61) · Cognitive Dysfunction (43) · Anxiety Disorders (34) · Depressive Disorder, Major (31) · Depression (28) · Stress Disorders, Post-Traumatic (28) · Substance-Related Disorders (26) · Schizophrenia (23) · Alcoholism (20) · Attention Deficit Disorder with Hyperactivity (18) · Erectile Dysfunction (17) · Dementia (15) · Autism Spectrum Disorder (12) · Marijuana Abuse (12) · Opioid-Related Disorders (12)
Nervous System Diseases (147) · Neurocognitive Disorders (130) · Brain Diseases (101) · Central Nervous System Diseases (101) · Chemically-Induced Disorders (86) · Neurodegenerative Diseases (82) · Pathological Conditions, Signs and Symptoms (74) · Dementia (71) · Tauopathies (62) · Behavior (61) · Substance-Related Disorders (57) · Signs and Symptoms (55) · Mood Disorders (50) · Cognition Disorders (46)
Psilocybin (11) · Ketamine (10) · Transcranial Magnetic Stimulation (9) · Cognitive Behavioral Therapy (8) · Donepezil (8) · Transcranial Direct Current Stimulation (7) · Melatonin (6) · Buprenorphine (5) · Dexmedetomidine (5) · Memantine (5) · Propranolol (5) · Sodium Chloride (5) · Standard of Care (5) · Behavior Therapy (4) · Buprenorphine, Naloxone Drug Combination (4)
Chang Gung Memorial Hospital (9) · University of Sao Paulo (6) · Douglas Mental Health University Institute (5) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (5) · The University of New South Wales (5) · National Institute on Drug Abuse (NIDA) (4) · Ruijin Hospital (4) · Shalvata Mental Health Center (4) · The University of Tennessee, Knoxville (4) · University Hospital, Clermont-Ferrand (4) · University of British Columbia (4) · University of Sao Paulo General Hospital (4) · Cairo University (3) · Chaitanya Hospital, Pune (3) · Evon Medics LLC (3)
United States (117) · China (41) · Canada (38) · Israel (23) · Brazil (22) · Taiwan (14) · France (13) · Germany (13) · Egypt (12) · South Korea (12) · United Kingdom (12) · Australia (10) · Spain (9) · Denmark (8) · Netherlands (7)
Alain Brunet, Ph.D. (3) · Bomin Sun, MD, PhD (3) · Douglas C Smith, PhD (2) · Edwin Chapman, MD (2) · Evaristus Nwulia, MD (2) · Gordon B Parker, Dsc MD PhD (2) · June P Tangney, Ph.D. (2) · Kirsten C Morley, PhD (2) · Marc Fishman, MD (2) · Richard P Mattick, PhD (2) · Scott Aaronson, MD (2) · Shahin Akhondzadeh, Ph.D. (2) · Tanya Alim, MD (2)
PMID 20565514, PMID 25150403, PMID 32368793, PMID 38419905, PMID 10193207, PMID 10917410, PMID 10990547, PMID 11063978, PMID 11723286, PMID 12244081, PMID 12567277, PMID 12849360, PMID 12873949, PMID 12949224, PMID 1409977, PMID 14677403, PMID 15026214, PMID 15147306, PMID 1517644, PMID 15212606, PMID 15328899, PMID 15351385, PMID 15919269, PMID 15987799, PMID 16002441, PMID 16142633, PMID 16320215, PMID 16360929, PMID 16441069, PMID 16794566, PMID 16876832, PMID 16930894, PMID 17341537, PMID 17562493, PMID 17591596, PMID 18176908, PMID 19148734, PMID 19149817, PMID 19332318, PMID 19403329, PMID 19671217, PMID 19853048, PMID 20075648, PMID 20146803, PMID 20204386, PMID 20633386, PMID 20815872, PMID 20884642, PMID 21068312, PMID 21167786
2015 (2), R01DA014694 (2), 2005 (1), 2009 (1), 2014 (1), 2016 (1), 2017 (1), 2018 (1), 2019 (1), 2023 (1), K01DA019446 (1), K23DA021512 (1), P20GM103425 (1), P20RR020146 (1), P30AG024978 (1)